Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Interim Management Statement

10 Jul 2013 14:40

RNS Number : 0370J
Maven Income & Growth VCT PLC
10 July 2013
 



Maven Income and Growth VCT PLC (the Company)

 

Interim Management Statement - Quarter Ended 31 May 2013

 

This Interim Management Statement, for the quarter ended 31 May 2013, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 June 2013 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

·; Net asset value (NAV)1 of 70.9p per share at 31 May 2013, compared to 70.6p per share at 28 February 2013;

·; NAV total return2 of 120.5p at 31 May 2013, compared to 120.2p at 28 February 2013; and

·; Final dividend of 3.5p per share in respect of the year ending 28 February 2013 to be paid on 19 July 2013.

 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 31 May 2013. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 28 February 2013, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

 

2.

Investments and disposals

 

During the quarter ended 31 May 2013, a total of £106,258 was invested in support of three existing portfolio companies and an aggregate £2,294,429 was invested in two new unlisted investments. During the same period, net proceeds of £2,001,634 were realised from UK government securities; the sale of an AIM quoted holding realised proceeds of £12,283 against cost of £8,233; and the full or partial disposal of five unlisted holdings realised total proceeds of £2,914,300 against an aggregate cost of £1,176,191.

 

3.

Recent developments

 

Between 1 June 2013 and the date of this Statement, the Company provided an additional aggregate investment of £321,540 in support of two existing portfolio companies and made a total net investment of £3,433,352 in five new private companies. During the same period, £1,500,000 of proceeds were realised from UK government securities; and the partial disposal of three unlisted or AIM quoted holdings realised proceeds of £221,316 against an invested cost of £290,330.

 

Other than as described above, and changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 March 2013 to 31 May 2013, or in the period from 1 June 2013 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

10 July 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGURWMUPWGWU
Date   Source Headline
24th Aug 20153:33 pmRNSStatement re Dividend Investment Scheme
17th Jul 20154:33 pmRNSIssue of Equity
17th Jul 201510:42 amRNSNet Asset Value(s)
9th Jul 20154:23 pmRNSNet Asset Value(s)
9th Jul 20154:16 pmRNSDirectorate Change
9th Jul 20154:11 pmRNSResult of AGM
5th Jun 20154:35 pmRNSAnnual Financial Report
6th May 20152:26 pmRNSStatement re NAV & Proposed Dividend Declaration
13th Apr 20153:08 pmRNSIssue of Equity
27th Mar 20154:46 pmRNSDirector/PDMR Shareholding
27th Mar 20154:45 pmRNSDirector/PDMR Shareholding
27th Mar 20154:45 pmRNSDirector/PDMR Shareholding
20th Mar 20154:52 pmRNSIssue of Equity
26th Feb 201512:09 pmRNSIssue of Equity
26th Feb 201510:41 amRNSDirector/PDMR Shareholding
26th Feb 201510:38 amRNSDirector/PDMR Shareholding
26th Feb 201510:38 amRNSDirector/PDMR Shareholding
20th Feb 20152:44 pmRNSIssue of Equity
5th Feb 20155:00 pmRNSStatement re Offers for Subscription
3rd Feb 20153:07 pmRNSStatement re Offers for Subscription
30th Jan 20154:53 pmRNSStatement re Offers for Subscription
28th Jan 20152:21 pmRNSNet Asset Value(s)
21st Jan 20153:47 pmRNSStatement re Offers and Related Party Transactions
20th Jan 20159:48 amRNSStatement re Offers for Subscription
7th Jan 20152:11 pmRNSStatement re Offers for Subscription
28th Nov 20144:22 pmRNSTransaction in Own Shares
28th Oct 20147:00 amRNSHalf Yearly Report
20th Oct 20146:27 pmRNSStatement re Prospectus and Circular
10th Oct 20149:57 amRNSNet Asset Value(s)
3rd Oct 20144:20 pmRNSTotal Voting Rights
1st Oct 201410:50 amRNSStatement re Joint Offer for Subscription
5th Aug 20144:05 pmRNSTransaction in Own Shares
4th Aug 20144:28 pmRNSTransaction in Own Shares
31st Jul 20143:51 pmRNSTransaction in Own Shares
11th Jul 20142:46 pmRNSInterim Management Statement
10th Jul 20142:06 pmRNSResult of AGM
4th Jul 20144:28 pmRNSReplacement re Issue of Equity
2nd Jul 20149:45 amRNSIssue of Equity
6th Jun 20144:48 pmRNSAnnual Financial Report
28th May 20145:07 pmRNSOffer for Subscription Update
21st May 20149:55 amRNSNet Asset Value(s)
30th Apr 20147:01 amRNSStatement re Offer for Subscription
24th Apr 20142:43 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 20144:11 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:27 amRNSIssue of Equity
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary Prospectus
17th Feb 201412:31 pmRNSDirector/PDMR Shareholding
10th Feb 20146:02 pmRNSOffer for Subscription - Supplementary Prospectus
5th Feb 20144:16 pmRNSIssue of Equity
23rd Jan 20142:53 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.